Join correspondent Olga Villaverde as she explores innovations in the early detection of lung cancer.
Abbott is a company that makes everything from nutritional supplements to life-saving medical devices. They are trying to demystify the world of clinical trials and make them more accessible to the people who could benefit the most from them.
Each year, some 300,000 people in the United States contract Lyme disease. Early detection and treatment are key. Now there’s a new rapid test that can change the game.
Chronic heartburn, if left untreated and becomes severe, has been linked with a condition called Barrett's esophagus, which may lead to esophageal cancer. EsoGuard is an esophageal DNA test that is minimally invasive.
What you need to know about nOH, a condition that impacts patients who have underlying neurologic conditions.